Skip to main
VRTX
VRTX logo

Vertex Pharmaceuticals (VRTX) Market Capitalization Overview

Market Cap: $114.33B as of Jun 30, 2025

$114.33B
Past Month+$808.92M (0.71%)
As of Jun 30, 2025, Vertex Pharmaceuticals (VRTX) has a market capitalization of $114.33B. Over the past 30 days, its market cap has decreased by -10.81%, while in the last 12 months, it has increased by 10.24%.

Market capitalization represents the total value of Vertex Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Vertex Pharmaceuticals (VRTX) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Vertex Pharmaceuticals (VRTX) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Vertex Pharmaceuticals (VRTX) Market Cap History

DateMarket CapChange
Jun 2, 2025$114.39B-10.81%
May 1, 2025$128.25B+3.03%
Apr 1, 2025$124.48B+0.30%
Mar 3, 2025$124.11B+2.46%
Feb 3, 2025$121.14B+15.92%
Jan 2, 2025$104.50B-12.88%

Vertex Pharmaceuticals (VRTX) End of Year Market Cap History

DateMarket CapChange
2025$114.33B+10.24%
2024$103.71B-1.09%
2023$104.85B+41.44%
2022$74.13B+32.76%
2021$55.84B-9.15%
2020$61.46B

FAQs About Vertex Pharmaceuticals (VRTX) Market Cap

As of Jun 30, 2025, the market capitalization of Vertex Pharmaceuticals (VRTX) is $114.33B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Vertex Pharmaceuticals’s market capitalization has increased by 0.7100%, changing from $113.52B to $114.33B as of Jun 30, 2025.

In the last 3 months, Vertex Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Vertex Pharmaceuticals’s market capitalization decreased from $104.85B in January to $103.71B in December, reflecting a -1.09% change.

In the past five years, Vertex Pharmaceuticals (VRTX) has had a compound annual growth rate (CAGR) of 11.03% in market capitalization. This means its market cap has grown at an average rate of 11.03% per year.

Vertex Pharmaceuticals (VRTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.